Regenxbio
RGNX
RGNX
181 hedge funds and large institutions have $1.4B invested in Regenxbio in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 54 reducing their positions, and 17 closing their positions.
Holders
181
Holders Change
+9
Holders Change %
+5.23%
% of All Funds
3.18%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
71
Reduced
54
Closed
17
Calls
$5.36M
Puts
$28.2M
Net Calls
-$22.8M
Net Calls Change
-$33.9M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$174M |
| 2 |
ACM
2
Aquilo Capital Management
San Francisco,
California
|
$35.2M |
| 3 |
3
First Manhattan
New York
|
$23.8M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$102M |
| 5 |
5
BlackRock
New York
|
$267M |
Top Sellers
| 1 |
SI
1
Sofinnova Investments
Menlo Park,
California
|
$5.35M |
| 2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$28M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$10.1M |
| 4 |
4
D.E. Shaw & Co
New York
|
$2.53M |
| 5 |
5
Millennium Management
New York
|
$259K |
